Update on Chemotherapy in the Treatment of Urothelial Carcinoma

Urothelial carcinoma is the fifth most common malignancy diagnosed each year in the United States. Neoadjuvant and adjuvant chemotherapy are given to decrease the risk of recurrent or metastatic disease with the more robust clinical data supporting the former. Bladder preservation utilizes a trimoda...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantini, Carrie, Millard, Frederick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217602/
https://www.ncbi.nlm.nih.gov/pubmed/22125450
http://dx.doi.org/10.1100/2011/590175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217602/
https://www.ncbi.nlm.nih.gov/pubmed/22125450
http://dx.doi.org/10.1100/2011/590175

Ejemplares similares